On November 16, Rocket Lab USA, Inc. fell 4.11% in Pre-Market Trading to $59.09, with turnover of $3.7376 million.
The move coincided with continued market digestion of the company’s recent quarterly earnings miss, small analyst price-target cuts, and uncertainty tied to its proposed roughly $8 billion acquisition of Iridium.
Background details show third-quarter revenue rose 73% year over year to $267.8 million, ahead of expectations, but per-share loss came in at $0.12, worse than expected. Morgan Stanley trimmed its target price to $103 from $105, while Needham cut its target to $100; both maintained constructive views. The company had also said its 100th Electron launch was scheduled for November 14, but the latest price action appears more closely linked to lingering earnings and deal-related pressure than to that operational milestone.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments